Fifth Third Bancorp’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Fifth Third Bancorp’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,750	Closed	-$37K	–	2315
2020 Q1	$37K	Sell	9,750 -4,000	-29%	-$17.2K	﹤0.01%	1374
2019 Q4	$70K	Hold	13,750	–	–	﹤0.01%	1293
2019 Q3	$70K	Sell	13,750 -2,000	-13%	-$9.97K	﹤0.01%	1254
2019 Q2	$97K	Hold	15,750	–	–	﹤0.01%	1143
2019 Q1	$73K	Hold	15,750	–	–	﹤0.01%	1162
2018 Q4	$66K	Buy	15,750 +4,750	+43%	+$24.2K	﹤0.01%	1156
2018 Q3	$69K	Buy	11,000 +4,500	+69%	+$34.6K	﹤0.01%	1220
2018 Q2	$52K	Sell	6,500 -3,800	-37%	-$29K	﹤0.01%	1309
2018 Q1	$77K	Buy	10,300 +5,300	+106%	+$35.2K	﹤0.01%	1184
2017 Q4	$30K	Hold	5,000	–	–	﹤0.01%	1468
2017 Q3	$37K	Hold	5,000	–	–	﹤0.01%	1397
2017 Q2	$34K	Hold	5,000	–	–	﹤0.01%	1414
2017 Q1	$47K	Hold	5,000	–	–	﹤0.01%	1322
2016 Q4	$43K	Hold	5,000	–	–	﹤0.01%	1381
2016 Q3	$32K	Hold	5,000	–	–	﹤0.01%	1473
2016 Q2	$21K	Hold	5,000	–	–	﹤0.01%	1563
2016 Q1	$22K	Hold	5,000	–	–	﹤0.01%	1595
2015 Q4	$31K	Hold	5,000	–	–	﹤0.01%	1545
2015 Q3	$29K	Hold	5,000	–	–	﹤0.01%	1588
2015 Q2	$37K	Hold	5,000	–	–	﹤0.01%	1577
2015 Q1	$30K	Hold	5,000	–	–	﹤0.01%	1602
2014 Q4	$38K	Hold	5,000	–	–	﹤0.01%	1494
2014 Q3	$26K	Sell	5,000 -30	-0.6%	-$150	﹤0.01%	1672
2014 Q2	$22K	Buy	5,030 +30	+0.6%	+$115	﹤0.01%	1777
2014 Q1	$20K	Hold	5,000	–	–	﹤0.01%	1799
2013 Q4	$27K	Sell	5,000 -500	-9%	-$2.2K	﹤0.01%	1562
2013 Q3	$28K	Buy	5,500 +500	+10%	+$2.71K	﹤0.01%	1551
2013 Q2	$22K	Buy	+5,000	New	+$22.4K	﹤0.01%	1572

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Fifth Third Bancorp's PGNX Position: Q2 2020 in Review

Fifth Third Bancorp sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 9,750 shares — an estimated $37K sold.

Fifth Third Bancorp first reported a position in PGNX in Q2 2013 and held it in 28 quarters. The position peaked at $97K in Q2 2019. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Fifth Third Bancorp reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Fifth Third Bancorp sold 9,750 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $37K.
Fifth Third Bancorp first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 28 quarters.
Fifth Third Bancorp's Progenics Pharmaceuticals Inc position peaked at $97K in Q2 2019.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Fifth Third Bancorp's 13F filing for Q2 2020, filed 5 Aug 2020.